– CTRA to be acquired by DVN for 0.7x shares, -2.4% discount, $25.0 billion
– FOM.to to be acquired by ELD.to for $0.01 cash + 0.1128x shares, 0.1% premium, $3.8 billion
– NFBK to be acquired by CLBK for $14.25 per share (30% cash), 15.7% premium, $597 million
– FSFG / FRME deal closed
– CADE / HBAN deal closed
– PCH / RYN deal closed
– CMA / FITB deal closed
– REVG / TEX deal closed
– RAPT / GSK launched tender offer, expires Mar 2
– FOLD / BMRN filed DEFM14a, vote Mar 3, closing Q2 2026
– HTBK / CVBF filed S-4, closing Q2 2026
– RNA / NVS filed DEFM14a, vote Feb 23, closing H1 2026
– NGD / CDE obtained court approval, closing H1 2026
– NWE / BKH filed S-4, closing H2 2026, vote Apr 2
– TWO / UWMC filed S-4, filed HSR Jan 26, closing Q2 2026
– JHG / Trian Fund Management / General Catalyst filed PREM14a, closing mid 2026